Epilepsy with myoclonic absences (EMA) is a rare childhood generalised epilepsy syndrome in which the predominant seizure type combines impaired awareness with rhythmic myoclonic jerking, usually affecting the shoulders and upper limbs.
The syndrome is distinct from ordinary typical absence epilepsy because the rhythmic motor component is central to the seizure rather than a minor accompanying movement.
The defining seizure
A myoclonic absence seizure combines an absence with rhythmic bilateral jerking, often involving the shoulders, arms and sometimes head.
The jerks occur in time with the generalised spike-wave discharge and can be accompanied by progressive elevation of the arms.
Awareness
Awareness is impaired during the event, as in other absence seizures.
The child may stop responding while the rhythmic myoclonic movements continue for several seconds.
How often seizures occur
The ILAE describes daily myoclonic absence seizures as characteristic of the syndrome.
Because the events can be frequent, they can substantially interfere with learning, conversation and daily activity.
Age at onset
EMA is a childhood-onset syndrome. The precise age range is broader than in some other absence syndromes, and diagnosis relies more strongly on the characteristic seizure and EEG combination.
The EEG pattern
The mandatory EEG feature is a regular generalised 3-Hz spike-wave pattern that is time-locked with the myoclonic jerks.
This tight electroclinical relationship helps distinguish true myoclonic absence seizures from ordinary absence seizures accompanied by occasional small movements.
What argues against EMA?
Focal seizures, atonic seizures, myoclonic-atonic seizures and tonic seizures are exclusionary in the ILAE syndrome criteria.
Persistent focal slowing, consistently unilateral focal spikes, very slow generalised spike-wave or diffuse background slowing also suggest another syndrome or underlying disorder.
MRI
MRI is usually normal when the syndrome is idiopathic or genetic.
Imaging may be performed when the presentation is atypical or when developmental or neurological abnormalities suggest another cause.
Development and cognition
Developmental or learning difficulties are more common than in classic childhood absence epilepsy.
Some children have normal development at onset, while others have pre-existing cognitive difficulties or develop problems during the active epilepsy.
Why this is not juvenile myoclonic epilepsy
JME causes brief myoclonic jerks with preserved awareness, usually after waking, and does not characteristically produce myoclonic absence seizures.
EMA instead combines rhythmic jerks with a true absence and a time-locked 3-Hz generalised spike-wave discharge.
Why this is not epilepsy with myoclonic-atonic seizures
Myoclonic-atonic seizures begin with a brief jerk followed by loss of muscle tone, which can produce a head drop or fall.
EMA lacks that defining atonic component.
Treatment
Evidence is limited because EMA is rare and there are few controlled trials. Broad-spectrum medicines used for generalised epilepsies are commonly selected.
Valproate, ethosuximide, lamotrigine, clobazam and other broad-spectrum treatments have been used, often in combination when seizures are resistant.
Why treatment evidence should be presented cautiously
Most published treatment information comes from small cohorts and retrospective experience rather than large randomised trials.
For that reason, it is more accurate to describe commonly used therapies than to claim one universally proven first-line treatment.
Drug resistance
Seizures can be difficult to control in some children, particularly when additional seizure types or developmental problems are present.
Persistent daily seizures can have a major effect on education and quality of life even when they are individually brief.
Prognosis
Outcome is variable. Some children achieve good seizure control, while others continue to have epilepsy and cognitive difficulties.
The presence of additional epilepsy features or an underlying genetic disorder can influence long-term outcome.
Genetic investigation
EMA is considered a generalised epilepsy syndrome, but several genetic causes and broader neurodevelopmental disorders can produce an EMA-like phenotype.
Genetic testing is particularly relevant when there is intellectual disability, unusual neurological findings, drug resistance or a strong family history.
Worldwide diagnosis
Diagnosis depends heavily on EEG because the rhythmic motor movements need to be shown to occur with the generalised 3-Hz spike-wave discharge.
This creates a diagnostic challenge in regions where video-EEG or even routine EEG is difficult to access.
The central point
A myoclonic absence is not simply an absence plus an occasional jerk. It is a specific electroclinical seizure in which rhythmic bilateral myoclonus is time-locked to the generalised 3-Hz spike-wave discharge.
Related reading
Epilepsy Syndromes →
Childhood Absence Epilepsy →
Juvenile Myoclonic Epilepsy →
EEG Explained Properly →
Sources
- ILAE — Classification and definition of epilepsy syndromes with onset in childhood
- ILAE childhood epilepsy syndrome position paper
Medical note: myoclonic absence seizures require EEG confirmation because several other seizure and movement patterns can look similar.
Evidence checked: September 2026.